BioCentury
ARTICLE | Clinical News

Matritech regulatory update

November 14, 1994 8:00 AM UTC

Matritech Inc. (NMPS) The Cambridge, Mass., company filed for FDA approval of its Matritech NMP22 Test Kit for bladder cancer. The urine test uses NMPS's nuclear matrix protein (NMP) technology, whic...